19 October 2026 Dispatch of Annual General Meeting Documents Argent BioPharma provides the following documents regarding its Annual General Meeting of shareholders being held at 10:00AM (AWST) on Friday, 20 November 2026, at Suite 1, 295 Rokeby Road, Subiaco, WA 6008. • Notice and...
Argent Biopharma: Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 47 pages · English
Summary by 6ix AI
Argent Biopharma Ltd has issued a notice regarding its upcoming Annual General Meeting, scheduled for a specific date and time. The notice includes details about the meeting's location, business agenda, and various resolutions to be voted on by shareholders. Key resolutions include the adoption of the remuneration report, election and re-election of directors, and approval for issuing convertible notes and options. Shareholders are encouraged to participate either in person or by proxy, with specific instructions provided for voting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Argent Biopharma
- Date of AGM and Closing Date for Director Nominations
- Strategic Focus on Immune Modulation and Longevity
- Application for quotation of securities - RGT
- Execution of Loan Facility Agreement
- Argent Signs NLC Licence to Expand Antiviral Portfolio
Later from Argent Biopharma
- Quarterly Activities/Appendix 4C Cash Flow Report
- RGT Executes Global Licence for Non-Core Cannabis Genetics
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma